Treatment of primary Raynaud's syndrome with traditional Chinese acupuncture

Journal of Internal Medicine

Volumn 241, Issue 2, 1997, Pages 119-124

  Appiah, R ^a   Hiller, S ^a   Caspary, L ^a   Alexander, K ^a   Creutzig, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acupuncture therapy; Capillaroscopy; Laser Doppler flowmetry; Peripheral vascular disease; Raynaud's syndrome

Indexed keywords

ACUPUNCTURE; ADULT; ARTICLE; CAPILLAROSCOPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; TREATMENT OUTCOME;

EID: 0031044568     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.91105000.x     Document Type: Article

References (37)

1. Heidrich H. Das Raynaud-Syndrom. Df Ärztebe 1993; 90: C-2214-9.
2. Cesarone MR, Laurora G, Smith SRG, Belcaro G. Laser-Doppler flowmetry in the assessment of 'mild' Raynaud's phenomenon and its treatment. Panminerva Medica 1990; 32: 151-4.
3. Weber A, Bounameaux H. Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease. J Cardiovasc Pharmacol 1990; 15: 844-53.
4. Kahan A, Amor B, Menkes CJ. Nifedipine and allied substances in the treatment of Raynaud's phenomenon. Adv Microcirc 1985: 12: 95-104.
5. Smith CD, McKendry RJR. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Lancet 1982; ii: 1299-301.
6. Kallenberg CGM, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H. Nifedipine in Raynaud's phenomenon: relationship between immediate, short-term and long-term effects. J Rheumatol 1987; 14: 284-90.
7. Rademaker M, Cooke ED, Almond NE, Beacham JA, Smith RE, Mant TGK, et al. Comparison of intravenous infusion of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomized study. Br Med J 1989; 298: 561-4.
8. Freedman RR. Behavioral treatment of Raynaud's disease and phenomenon. Adv Microcirc 1985; 12: 138-56.
9. Jobe JB, Roberts DR, Sampson JB. Conditioning therapy in Raynaud's phenomenon. Adv Microcirc 1985; 12: 127-37.
10. Keefe FJ, Surwit RS, Pilon RN. Biofeedback, autogenic training, and progressive relaxation in the treatment of Raynaud's disease: a comparative study. J Appl Behav Anal 1980; 13: 3-11.
11. Celoria R, Conci F, Bonelli T. Variazioni di quadri angiografici nel morbo di Raynaud in seguito a trattamento reflessoterapico. Min Med 1977; 68: 693-702.
12. Jiazhu B. Acupuncture treatment of Raynaud's disease - a report of 43 cases. J Trad Chin Med 1988; 8: 257-9.
13. Kaada B. Vasodilatation induced by transcutaneous nerve stimulation in peripheral ischemia (Raynaud's phenomenon and diabetic polyneuropathy). Eur Heart J 1982; 3: 303-14.
14. Allen EV, Brown GE. Raynaud's disease: a critical review of minimal requisites for diagnosis. Am J Med Sci 1931; 183: 187-200.
15. Xinong C. Chinese Acupuncture and Moxibustion. Beijing: Foreign Language Press, 1987.
16. Mahler F, Saner H, Würbel H, Flammer J. Local cooling test for clinical capillaroscopy in Raynaud's phenomenon, unstable angina, and vasospastic visual disorders. Vasa 1989; 18: 201-4.
17. Mahler F, Saner H, Boss C, Annaheim M. Local cold exposure test for capillaroscopic examination of patients with Raynaud's syndrome. Microvasc Res 1987; 33: 422-7.
18. Mahler F, Saner H, Annaheim M, Linder HR. Capillaroscopic evaluation of erythrocyte flow velocity in patients with Raynaud's syndrome by means of a local cold exposure test. Prog Appl Microcirc 1986; 11: 47-59.
19. Plotz CM, Plotz PH, Lamont-Havers RW. Workshop on the use of acupuncture in the rheumatic diseases - summary of proceedings. National Institutes of Health, Bethesda, Maryland, September 17-18, 1973. Arthritis Rheum 1974; 17: 939-43.
20. Coffman JD, Clement DL, Craeger MA, Dormandy JA, Janssens MM-L, McKendry JR, et al. International study of ketanserin in Raynaud's phenomenon. Am J Med 1989; 87: 264-8.
21. Gøtzsche PC. Is there logic in the placebo? Lancet 1994; 344: 925-6.
22. Coffman JD, Cohen RA. Total and capillary fingertip blood flow in Raynaud's phenomenon. N Engl J Med 1971; 285: 259-63.
23. Gasser P, Flammer J. Die dynamisch-video-kapillarmikroskopische Beeinflußung akraler und okulärer Vasospasmen durch Kalzium- und Serotoninantagonisten. Vasa 1989; Suppl. 27: 79-81.
24. LeQuentrec P, Lefebvre ML. Double-blind placebo-controlled trial of buftomedil in the treatment of Raynaud's phenomenon: a six-month follow up. Angiology 1991; 42: 289-95.
25. Miyazaki S, Kosaka J, Miura K. Captopril treatment of Raynaud's phenomenon. Importance of relationships between plasma kinins and α-adrenergic systems. Adv Microcirc 1985; 12: 105-18.
26. Rhedda A, McCans J, Willan AR, Ford PM. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon. J Rheumatol 1985; 12: 724-7.
27. Russell IJ, Lessard JA. Prazosin treatment of Raynaud's phenomenon: a double blind single crossover study. J Rheumatol 1985; 12: 94-8.
28. Wollersheim H, Thien T. Dose-response study of prazosin in Raynaud's phenomenon: clinical effectiveness versus side effects. J Clin Pharmacol 1988; 28: 1089-93.
29. Dowd PM, Goldsmith PC, Bull HA, Burnstock G, Foreman JC, Marshall I. Raynaud's phenomenon. Lancet 1995; 346: 283-90.
30. Lundeberg T. Peripheral effects of sensory nerve stimulation (acupuncture) in inflammation and ischemia. Scand J Rehabil Med 1993; Suppl. 29: 61-86.
31. Engelhart M. Clinical and physiological studies of Raynaud's phenomenon. Dan Med Bull 1991; 38: 458-68.
32. Engelhart M. The effect of sympathetic blockade and cooling in Raynaud's phenomenon. Clin Physiol 1990; 10: 131-6.
33. Yao T. Acupuncture and somatic nerve stimulation: mechanism underlying effects on cardiovascular and renal activities. Scand J Rehab Med 1993; Suppl. 29: 7-18.
34. Kashiba H, Ueda Y. Acupuncture to the skin induces release of substance P and calcitonin gene-related peptide from peripheral terminals of primary sensory neurons in the rat. Am J Chin Med 1991; 19: 189-97.
35. Gennari C, Fischer JA. Cardiovascular action of calcitonin gene-related peptide in humans. Calcif Tissue Int 1985; 37: 581-4.
36. Bunker CB, Terenghi G, Springall DR, Polak JM, Dowd PM. Deficiency of calcitonine gene-related peptide in Raynaud's phenomenon. Lancet 1990; 336: 1530-3.
37. Kjartansson J, Lundeberg T, Samuelson UE, Dalsgaard C-J, Hedén P. Calcitonin gene-related peptide (CGRP) and transcutaneous electrical nerve stimulation (TENS) increase cutaneous blood flow in a musculocutaneous flap in the rat. Acta Physiol Scand 1988; 134: 89-94.